- ￥1536 - 2136
- ProteoGenix
- PTX19275
- France
- 2026年03月03日
企业认证
相关产品推荐更多 >
Vatelizumab Biosimilar Anti-ITGA2 mAb (Research Grade), Vatelizumab生物类似药 抗ITGA2单抗 (研究级)
￥2876MDX-1342 Biosimilar Anti-CD19 mAb (Research Grade), MDX-1342生物类似药 抗CD19单抗 (研究级)
￥2876
Research Grade Citatuzumab(Biosimilar 抗体), 研究级Citatuzumab(Biosimilar 抗体)
￥2288Sabatolimab Biosimilar Anti-HAVCR2 mAb (Research Grade), Sabatolimab生物类似药 抗HAVCR2单抗 (研究级)
￥1186Research Grade Mezagitamab(Biosimilar 抗体), 研究级Mezagitamab(Biosimilar 抗体)
￥2288
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
Anti-Human IgE/IGHE Monoclonal Antibody, SAA0342
- 抗体英文名：
Anti-Human IgE/IGHE Monoclonal Antibody, SAA0342
- 保质期：
1 year
- 目录编号：
PTX19275
- 级别：
科研级别
- 库存：
999
- 供应商：
ProteoGenix
- 保存条件：
4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles
- 亚型：
IgG1, kappa
- 规格：
50ug/100ug
| 规格： | 50ug | 产品价格： | ￥1536.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥2136.0 |
| Product name | Anti-Human IgE/IGHE Monoclonal Antibody, SAA0342 |
| Species | Human |
| Isotype | IgG1, kappa |
| Expression system | nan |
| Buffer | 0.01M PBS, pH 7.4. |
| Aliases / Synonyms | nan |
| Delivery condition | Blue ice (+4°) |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Kit content | nan |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity
One of the major reasons for seeking human monoclonal antibodies has been to eliminate immunogenicity seen with rodent antibodies. Thus far, there has yet been no approach which absolutely abolishes that risk for cell-binding antibodies
Generation of a Monoclonal Antibody Library Against Human Embryonic Stem Cells
Differentiated cell types derived from human embryonic stem cells (hESCs) may serve in the future to treat various human diseases and to model early human embryonic development in vitro. Fulfilling this potential, however, requires extensive
patterns rather than individual protein markers. The development of an antibody microarray platform of general applicability requires careful consideration of the array content. The human cluster of differentiation (CD) antigens constitute a promising
技术资料暂无技术资料 索取技术资料
